Document:

EX-10.3

 Exhibit 10.3 

EMPLOYMENT AGREEMENT 
 This
Employment Agreement, dated as of March 1, 2021 (this “Agreement”), is made and entered into by and between STRATA Skin Sciences, Inc., a Delaware corporation (“Company”) and Robert Moccia, an adult individual
(“Executive”). Terms used herein and not otherwise defined shall have the meanings set forth in Section 11. 
 RECITALS

 WHEREAS, subject to the terms and conditions hereinafter set forth, Company wishes to employ Executive as its President and Chief
Executive Officer and Executive wishes to be employed by Company as its President and Chief Executive Officer. 
 NOW, THEREFORE, in
consideration of the foregoing premises and the mutual promises, terms, provisions and conditions set forth in this Agreement, the adequacy and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby
agree as follows: 
 AGREEMENT 

1. Employment. Subject to the terms and conditions set forth in this Agreement, Company hereby offers and Executive hereby accepts
employment with Company, as of the date first above written (the “Start Date”). 
 2. Term. Subject to Section 5,
Executive’s employment under the terms of this Agreement be for a period (the “Term”) commencing on the Start Date and continuing until the third (3rd) anniversary of the Start Date
(the “Term End Date”), provided, however, that unless a party has given the other party written notice at least ninety (90) days prior to the Term End Date (or any anniversary of the Term End Date) that such party does not agree to
renew this Agreement, the term of this Agreement and the Term shall be deemed renewed for a term ending one (1) year subsequent to the Term End Date (or anniversary of the Term End Date). The parties may terminate this Agreement and
Executive’s employment hereunder during the Term in accordance with, and subject to the provisions of, Section 5. 
 3.
Capacity and Performance. 
 (a) During the Term, Executive shall be employed by Company on a
full-time basis as its President and Chief Executive Officer. Executive shall perform such duties and responsibilities consistent with Executive’s position on behalf of Company. 

(b) Executive’s employment with Company shall be exclusive with respect to the Business of Company. Accordingly, during the Term,
Executive shall devote Executive’s full business time and Executive’s best efforts, business judgment, skill and knowledge to the advancement of the business and interests of Company and to the discharge of Executive’s duties and
responsibilities hereunder, except for permitted vacation (and other paid time off) periods, reasonable periods of illness or incapacity, and reasonable and customary time spent on civic, charitable and religious activities, in each case such
activities shall not interfere in any material respect with Executive’s duties and responsibilities hereunder. 

 (c) During the Term, Executive will report directly to the Board of Directors (the
“Board”). 
 (d) On the Start Date, the Board shall appoint Executive as a director of Company and shall, during the Term, nominate
and recommend Executive for election as a director. Executive acknowledges and agrees that Executive is not entitled to any additional compensation in respect of Executive’s appointment as a director of Company. If, during the Term, Executive
ceases to be a director of Company for any reason, Executive’s employment with the Company will continue (unless terminated in accordance with Section 5) and all terms of this Agreement (other than those relating to Executive’s
position as a director of Company) will continue in full force and effect and Executive will have no claims in respect of such cessation of office. Executive agrees to abide by all statutory, fiduciary or common law duties arising under applicable
law that apply to Executive as a director of Company. 
 (e) Executive shall be employed to perform his duties under this Agreement at the
principal office location of Company, which currently is in Horsham, Pennsylvania, or at such other location or locations as may be mutually agreeable to Executive and Company (including reasonable provisions during the
COVID-19 national public health emergency). Notwithstanding this, it is expected that Executive shall be required to travel a reasonable amount of time in the performance of his duties under this Agreement

 (f) Notwithstanding clauses (a), (b) and (e) of this Section 3, Executive may, until March 31, 2021, assist, without any
time or other restrictions, Encore Dermatology, Inc., in a consulting or advisory basis, with existing matters and pending work in process. 

4. Compensation and Benefits. 

(a) Base Salary. For services performed by Executive under this Agreement, Company shall pay Executive an annual base salary during the
Term at the rate of $500,000 per year, minus applicable withholdings and deductions, payable at the same times as salaries are payable to other executive employees of Company (the “Base Salary”). During the Term, the Base Salary shall
reviewed by the Board each year and the Board may, from time to time, increase such Base Salary and any reference to “Base Salary” herein shall refer to such Base Salary, as increased. 

(b) Annual Bonus. For each fiscal year of the Company during the Term, the Company shall afford Executive the opportunity to earn an
incentive bonus (“Bonus”) as described in this Section 4(b). The aggregate target Bonus payable to Executive under such program(s) shall equal sixty-five (65%) of the Base Salary for such fiscal year, and shall be payable to the
extent the applicable performance goals are achieved (which goals and payment matrices shall be set by the Compensation Committee in its discretion). The amount of the Bonus will be determined by certification by the Board that the applicable goals
have been achieved and the Board shall promptly provide such certification following achievement of the applicable goals. The amount payable under this Section 4(b) shall be paid by the seventh
(7th) day following the approval of the annual audited financial statements by the Board or its audit committee, as applicable, for the calendar year in which the Bonus is earned or, if later, the
fifteenth day of the third month following the end of the Company’s fiscal year in which the Bonus is earned. 

  
 2 

 (c) Initial Equity Award. On the Start Date, Executive shall award an equity award as
follows: 
 (i) Executive shall be awarded options (the “Options”) to purchase 1,632,590 shares of the Company’s common
stock. The Options shall be awarded as follows: 
 (A) The Options shall vest over a period of three (3) years, with 544,198 of the
Options vesting as of the first anniversary of the Start Date and 136,049 of the Options vesting on each of June 1, 2022, September 1, 2022, December 1, 2022, March 1, 2023, June 1, 2023, September 1, 2023,
December 1, 2023, March 1, 2024. 
 (B) The Options shall be subject to the reasonable and customary terms of a definitive option
award agreement, a form of which is attached hereto as Exhibit B. 
 (ii) The Options are intended to constitute an employment inducement
grant under Nasdaq Listing Rule 5635(c)(4), and consequently is intended to be exempt from the Nasdaq Listing Rules regarding stockholder approval of stock option or purchase plans. The Options and the terms and conditions of the Options shall be
interpreted in accordance and consistent with such exemption. 
 (d) Annual Equity Awards. For each fiscal year of the Company during
the Term, Executive shall be entitled to participate in all long-term incentive plans (including any equity incentive plan) sponsored by the Company either now or in the future, on terms and conditions similar to those applicable to other executive
officers of the Company generally. The amount and terms of the long-term incentive awards awarded to the Executive shall be set by the Compensation Committee in its discretion after consultation with a compensation consultant, if any, retained by
the Compensation Committee. 
 (e) Other Employee Benefits. During the Term, Executive shall be entitled to participate in any and all
employee benefit plans, including health and 401(k) plans, from time to time generally in effect for Company’s employees (collectively, “Benefit Plans”). Such participation and receipt of benefits under any such Benefit Plans shall be
on the same terms (including cost sharing between Company and Executive) as are applicable to other Company employees and shall be subject to the terms of the applicable plan documents and generally applicable Company policies. Company may alter,
modify, add to or delete the Benefit Plans in a manner nondiscriminatory to Executive at any time in accordance with applicable plan rules. The Company shall reimburse Executive for premiums paid by Executive to receive health continuation coverage
under his prior employer’s plans (pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”)) for the period of time from the Start Date through date the Executive is eligible to participate in the Company’s
medical, dental, vision plans. 

  
 3 

 (f) Vacation. The Executive shall be entitled to annual vacation of 20 days plus ten
established holiday days per full calendar year of his employment with the Company hereunder. Any unused vacation in one accrued calendar year may not be carried over to any subsequent calendar year. The Company shall, however, pay the Executive
(based on the Executive’s Base Salary) for any such unused vacation days within 30 days of the end of any such calendar year. 
 (g)
Business and Travel Expenses. Company shall pay or reimburse Executive for all reasonable, customary and necessary business expenses (including cell phone, travel, lodging and entertainment expenses) which are properly documented and incurred
or paid by Executive in the performance of Executive’s duties and responsibilities hereunder, subject to the rules, regulations and procedures of Company and in effect from time to time. 

(h) Automobile. Company shall provide Executive with an allowance of $1,250 per month for automobile and related maintenance costs..
Executive acknowledges that the Executive shall be responsible for keeping such records as may be necessary for tax purposes and that the provision and use of the automobile may generate compensation to Executive, and agrees that Company may
withhold from Executive’s Base Salary that amount which is necessary for Company to fully satisfy its withholding obligations under federal and state law. In addition, the Company shall reimburse the Executive for the miles for which he travels
for business purposes in accordance with the standard mileage rate as determined by the Internal Revenue Service. 
 (i) Change in Control
Transaction Bonus. During Executive’s employment, in the event that (i) a Change in Control (as that term is defined under the STRATA Skin Sciences, Inc. 2016 Omnibus Incentive Plan, as amended from time to time (the “Equity
Plan”)) has occurred, and (ii) as of such Change in Control, the price per share of Company’s common stock (the “Common Stock”) is two (2) times or more the price per share of the Common Stock as of the date of the
Start Date (as adjusted pursuant to Section 11.7(a) of the Equity Plan), Executive shall be paid a bonus (the “Change in Control Transaction Bonus”), in cash, equal to two (2) times the Base Salary as in effect immediately
prior to such Change in Control. If applicable, the Change in Control Transaction Bonus shall be paid in a lump sum within fifteen (15) days after the consummation of such Change in Control and following certification by the Board of the
occurrence of clauses (i) and (ii) above. 
 5. Termination of Employment; Severance Benefits. Notwithstanding the provisions of
Section 2, Executive’s employment hereunder shall terminate under the following circumstances: 
 (a) Death. If
Executive’s dies during the Term, Executive’s employment hereunder shall immediately and automatically terminate. In such event, Company shall pay to Executive’s designated beneficiary or, if no beneficiary has been designated by
Executive, to Executive’s estate, the Final Compensation. Company shall have no further obligation hereunder to Executive, Executive’s beneficiary, or Executive’s estate upon termination of Executive’s employment under this
Section 5(a) including, specifically, that the provisions of Section 5(d) shall not apply. 

  
 4 

 (b) Disability. 

(i) Company may terminate Executive’s employment hereunder due to Executive’s Disability during the Term by giving Executive thirty
(30) days’ written notice of its intent to terminate, but in no event shall such termination be effective prior to the expiration of the time periods in the definition of “Disability.” Notwithstanding the foregoing, Company will,
after engaging in an interactive process with Executive to discern whether reasonable accommodation(s) can be provided without undue hardship upon Company, offer Executive reasonable accommodation(s) to enable Executive to perform the essential
functions of Executive’s position to the extent required by the Americans with Disabilities Act, as amended, (“ADA”) and applicable state law (if any) before terminating Executive’s employment hereunder. Executive may decline
such reasonable accommodation, in which case Executive’s employment hereunder will terminate as provided in this subsection. 
 (ii) In
the event of such termination for Disability, Executive will receive Executive’s Final Compensation. Company shall have no further obligation hereunder to Executive upon termination of Executive’s employment under this Section 5(b),
including, specifically, that the provisions of Section 5(d) shall not apply. 
 (iii) Subject to Executive’s rights under the
Family and Medical Leave Act (“FMLA”) and the ADA, Company may designate another employee to act in Executive’s place during any period of Executive’s disability during which Executive is unable to perform the essential functions
of Executive’s position with or without a reasonable accommodation. Notwithstanding any such designation, Executive shall continue to receive the Base Salary in accordance with Section 4(a) and coverage under the Benefit Plans in
accordance with Section 4(b), to the extent permitted by the then-current terms of the applicable benefit plans and as provided under the FMLA, if applicable, until the earliest to occur of (A) the
end of the Term, (B) Executive becomes eligible for disability income benefits under Company’s disability income plan or (C) the termination of Executive’s employment. 

(iv) While receiving disability income payments under Company’s disability income plan (if applicable), Company will continue to pay to
Executive Executive’s Base Salary under Section 4(a), but may offset any such disability income payments Executive receives against the Base Salary payments. Executive will also continue to participate in the Benefit Plans in accordance
with Section 4(b) and the terms of such Benefit Plans, until the end of the Term or until the termination of Executive’s employment, whichever occurs first. 

(v) If any question arises as to whether during any period Executive has a Disability as defined herein, Executive may, and at the request of
Company shall, submit to a medical examination by a qualified, unbiased physician selected by Company and reasonably acceptable to Executive or Executive’s duly appointed guardian, if any, to determine whether Executive has a Disability and
such determination shall for the purposes of this Agreement be conclusive of the issue. 

  
 5 

 (c) By Company for Cause. Company may terminate Executive’s employment hereunder
for Cause, as defined in Section 11, at any time upon notice to Executive setting forth in reasonable detail the nature of such Cause. Upon the giving of notice of termination of Executive’s employment hereunder for Cause, Executive will
receive Executive’s Final Compensation. Except as provided herein, Company will have no further obligation to Executive upon termination of Executive’s employment under this Section 5(c). Any notice of termination of Executive’s
employment hereunder for Cause, or any notice to Executive regarding any event, condition or circumstance that, if not cured, if applicable, in accordance with the above, could give rise to a termination of Executive’s employment hereunder for
Cause, shall set forth in detail the applicable event(s), condition(s) or circumstance(s) constituting reason(s) or potential reason(s) for such termination hereunder. 

(d) By Company Other than for Cause or by Executive for Good Reason. Company may terminate Executive’s employment hereunder other
than for Cause at any time upon thirty (30) days’ written notice to Executive and Executive may terminate Executive’s employment hereunder for Good Reason at any time upon thirty (30) days’ written notice to Company. 

(i) In the event of a termination of Executive’s employment under this Section 5(d), in addition to the Final Compensation,
Executive shall receive: 
 (A) continuation of Executive’s Base Salary, at the rate in effect as of the date immediately preceding the
date of termination, until the earlier of (x) the Term End Date and (y) the first anniversary of the date of termination (provided, however if the date of termination is after the first anniversary of the Start Date, the period pursuant to
this subsection (y) shall be eighteen (18) months after the date of termination), payable in accordance with the Company’s regular payroll practices, less applicable withholdings, commencing at the conclusion of the period set forth
in Section 5(d)(iii), provided that the first installment of such payments shall include all amounts which would have been paid during the period between Executive’s date of termination and the date of such first installment; and 

(B) if the date of termination occurs after the end of a calendar year but prior to the date on which a Bonus is paid under Section 4(b),
payment of such Bonus as determined under Section 4(b) shall be at the time proscribed by Section 4(b); and 
 (C) payment of a pro-rata portion of the amount of Executive’s Bonus for the year in which termination occurs that would have been payable based on actual performance determined under the terms of the Bonus as then in effect
for such year, with such pro-rata portion calculated by multiplying the amount of such bonus for the year in which such termination occurs (as determined by the Board based on actual performance for such year)
by a number: (x) the numerator of which is the number of days worked by Executive during the year of such termination, and (y) the denominator of which is three hundred sixty-five (365), with such payment to be made after the determination
of the Bonus pursuant to Section 4(b). 
 (ii) If the Executive timely and properly elects health continuation coverage under the
Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), the Company shall reimburse the Executive for the monthly COBRA premium paid by the Executive for himself and his dependents. Such reimbursement shall be paid to the
Executive on the 1st day of the month immediately following the month in which the Executive timely remits the premium payment. The Executive shall be eligible to receive such reimbursement until the earliest of:

  
 6 

 
(A) the first anniversary of the date of termination (provided, however if the date of termination is after the first anniversary of the Start Date, the period pursuant to this subsection
(A) shall be eighteen (18) months after the date of termination); (B) the date the Executive is no longer eligible to receive COBRA continuation coverage; and (C) the date on which the Executive receives substantially similar coverage
from another employer or other source. 
 (iii) Any obligation of Company to Executive under this Section 5(d) (other than for the
Final Compensation or for benefits required by law) is conditioned upon Executive’s execution and delivery to Company and the expiration of all applicable statutory revocation periods of a release of claims in the form attached hereto as
Exhibit A (the “Executive Release”), provided, that the terms of such Executive Release provided, that the terms of such Executive Release shall be subject to modification to the extent necessary to comply with (a) the fact that more
than one employee is simultaneously being terminated by Company as part of a group termination decision or (b) changes in applicable law, if any, occurring after the date hereof and prior to the date such Executive Release is executed. 

(e) By Executive Other than for Good Reason. Executive may terminate Executive’s employment hereunder other than for Good Reason
upon thirty (30) days’ written notice to Company; provided, that Company may, in its sole and absolute discretion, by written notice accelerate such date of termination. In the event of a termination of Executive’s employment under
this Section 5(e), Executive will receive the Final Compensation. Company shall have no further obligation hereunder to Executive upon termination of Executive’s employment under this Section 5(e). 

6. Effect of Termination. 

(a) Upon termination of Executive’s employment hereunder and subject to the provisions of Section 5 and Section 6(c),
Company’s entire obligation to Executive shall be payment of Final Compensation. 
 (b) In connection with cessation of Executive’s
service as President and Chief Executive Officer of Company, Executive shall automatically resign as a member of the Board and the board of directors (or similar body) of any of Company’s affiliated companies (except to the extent Executive and
Company otherwise may agree in writing at the time). Executive hereby agrees that no further action is required by Executive or any of the preceding to make the transitions and resignations provided for in this paragraph effective, but Executive
nonetheless agrees to execute any documentation Company reasonably requests at the time to confirm it and to not reassume any such service or position without the written consent of Company. 

(c) Except as otherwise required by Consolidated Omnibus Budget Reconciliation Act or any similar federal or state law, benefits shall continue
or terminate pursuant to the terms of the applicable benefit plan or agreement, without regard to any continuation of Base Salary or other payment to Executive following such date of termination. 

(d) The provisions of this Section 6 shall apply to any termination of employment. Provisions of this Agreement will survive any
termination if so provided herein or if necessary or desirable to accomplish the purposes of other surviving provisions, including, without limitation, the obligations of Executive under Sections 7, 9 and 10. 

  
 7 

 (e) Any termination of Executive’s employment with Company under this Agreement shall
automatically be deemed to be simultaneous resignation of all other positions and titles (including any director positions) that Executive holds with Company and any affiliate or subsidiary thereof. This Section 6(d) shall constitute a
resignation notice for such purposes. 
 7. Confidential Information. 

(a) Executive acknowledges that Company continually develops Confidential Information, that Executive may develop Confidential Information for
Company and that Executive may learn of Confidential Information during the course of employment with Company. Executive will comply with the policies and procedures of Company for protecting Confidential Information and shall not disclose to any
Person or use, other than as required by applicable law, regulation or process or for the proper performance of Executive’s duties and responsibilities to Company, any Confidential Information obtained by Executive incident to Executive’s
employment or other association with Company. Executive understands that this restriction shall continue to apply after Executive’s employment terminates, regardless of the reason for such termination. 

(b) Notwithstanding anything contained in this Section 7 to the contrary, nothing contained herein shall prevent Executive from disclosing
any Confidential Information required by law, subpoena, court order or other legal process to be disclosed; provided, that, Executive shall give prompt written notice to Company of such requirement, disclose no more information than is so required
and cooperate, at Company’s cost and expense, with any attempt by Company to obtain a protective order or similar treatment with respect to such information. 

(c) Pursuant to the Defend Trade Secrets Act of 2016, Executive understands that: 

(i) Executive may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret
that is made in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and solely for the purpose of reporting or investigating a suspected violation of law; or is made in a complaint or other
document that is filed under seal in a lawsuit or other proceeding; and 
 (ii) if Executive files a lawsuit for retaliation by Company for
reporting a suspected violation of law Executive may disclose the employer’s trade secrets to Executive’s attorney and use the trade secret information in the court proceeding if Executive files any document containing the trade secret
under seal and does not disclose the trade secret, except pursuant to court order. 

  
 8 

 8. Assignment of Rights to Intellectual Property. Executive shall promptly and fully
disclose to Company all Intellectual Property developed for the benefit of Company in the course of Executive’s employment by Company. Executive hereby assigns and agrees to assign to Company (or as otherwise directed by Company)
Executive’s full right, title and interest in and to all such Intellectual Property. Executive agrees to execute any and all applications for domestic and foreign patents, copyrights or other proprietary rights and to do such other acts
(including without limitation the execution and delivery of instruments of further assurance or confirmation) requested by Company (at Company’s expense) to assign to Company the Intellectual Property developed for the benefit of Company in the
course of Executive’s employment by Company and to permit Company to enforce any patents, copyrights or other proprietary rights to the Intellectual Property. Executive will not charge Company for time spent in complying with these obligations.
All copyrightable works that Executive creates developed for the benefit of Company in the course of Executive’s employment by Company shall be considered “work made for hire.” 

9. Restricted Activities. Executive agrees that the restrictions on Executive’s activities during and after Executive’s
employment set forth below are necessary to protect the goodwill, Confidential Information and other legitimate interests of Company and its successors and assigns: 

(a) During the term of this Agreement and during the Restricted Period following termination of employment, Executive will not, without the
prior written consent of Company, directly or indirectly, and whether as principal or investor or as an employee, officer, director, manager, partner, consultant, agent, or otherwise, alone or in association with any other person, firm, corporation,
or other business organization, engage or otherwise become involved in a Competing Business (as defined below) in any country in which the Company conducted business during the Term; provided, however, that the provisions of this Section 9
shall apply solely to those activities of a Competing Business which are congruent with those activities with which Executive was personally involved or for which Executive was responsible while employed by Company or its subsidiaries during the
twelve (12) month period preceding termination of Executive’s employment. This Section 9 will not be violated, however, by (i) Executive’s investment of up to $100,000 in the aggregate in one or more publicly-traded companies that engage in a Competing Business, and (ii) Executive’s current investment in Encore Dermatology, Inc. “Competing Business” means a business or enterprise (other than
Company or its subsidiaries) engaged in dermatology and plastic surgery and any other business directly competing with the business of the Company as currently conducted or otherwise conducted by the Company during the Term. “Restricted
Period” means twelve (12) months. 
 (b) During the Term of this Agreement and during the Restricted Period (as defined above),
Executive will not engage in any Wrongful Solicitation (as defined below). A “Wrongful Solicitation” shall be deemed to occur when Executive directly or indirectly (except in the course of Executive’s employment with Company), for the
purpose of conducting or engaging in a Competing Business, calls upon, solicits, advises or otherwise does, or attempts to do, business with any Person who is, or was, during the then most recent 12-month
period, a customer of Company or any of its subsidiaries, or takes away or interferes or attempts to take away or interfere with any custom, trade, business, patronage or affairs of Company or any of its subsidiaries, or hires or attempts to hire
any Person who is, or was during the most recent 12-month period, an employee, officer, representative or agent of Company or any of its subsidiaries, or solicits, induces, or attempts to solicit or induce any
person who is an employee, officer, representative or agent of Company or any of its subsidiaries to leave the employ of Company or any of its subsidiaries, or violate the terms of their contract, or any employment agreement, with it. 

  
 9 

 (c) It is expressly understood and agreed that although Executive and Company consider the
restrictions contained in this Section 9 to be reasonable, if a final judicial determination is made by a court of competent jurisdiction that the time or territory or any other restriction contained in this Agreement is an unenforceable
restriction against Executive, the provisions of this Agreement shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as the court may judicially determine or indicate to be
enforceable. Alternatively, if any court of competent jurisdiction finds that any restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the
enforceability of any of the other restrictions contained herein. 
 (d) It is expressly understood by Executive that in the event of a
violation of any period specified in this Section 9, such period shall be extended by a period of time equal to that period beginning with the commencement of any such violation and ending when such violation shall have been finally terminated
in good faith. 
 (e) Notwithstanding anything contained in this Section 9, Executive’s service pursuant to Section 3(f) shall
not constitute a breach of this Section 9. 
 10. Enforcement of Covenants. Executive acknowledges that Executive has carefully
read and considered all the terms and conditions of this Agreement, including the restraints imposed upon Executive pursuant to Sections 7, 8 and 9. Executive agrees that these restraints are necessary for the reasonable and proper protection
of Company and its successors and assigns and that each and every one of the restraints is reasonable in respect to subject matter, length of time and geographic area. Executive further acknowledges that, were Executive to breach any of the
covenants contained in Sections 7, 8 and 9, the damage to Company would be irreparable. Executive therefore agrees that Company, in addition to any other remedies available to it, shall be entitled to preliminary and permanent injunctive relief
against any breach or threatened breach by Executive of any of the covenants herein, without any requirement to post a bond or similar security. The parties further agree that, in the event that any provision of Sections 7, 8 or 9 shall be
determined by any court of competent jurisdiction to be unenforceable by reason of its being extended over too great a time, too large a geographic area or too great a range of activities, such provision shall be deemed to be modified to permit its
enforcement to the maximum extent permitted by law. 
 11. Definitions. Words or phrases which are initially capitalized or are within
quotation marks shall have the meanings provided in this Section and as provided elsewhere herein. For purposes of this Agreement, the following definitions apply: 

(a) “Affiliate” means, with respect to any specified Person, any other Person which directly or indirectly through one or more
intermediaries controls, or is controlled by, or is under common control with, such specified Person (for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled
by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to either (i) direct or cause the direction of the management or policies of such Person,
whether through the ownership of voting securities, by agreement or otherwise or (ii) vote at least fifty percent (50%) or more of the securities having voting power for the election of a majority of the directors (or Persons performing similar
functions) of such Person. 

  
 10 

 (b) “Cause” means if Executive is discharged by Company on account of the
occurrence of one or more of the following events: 
 (i) Executive’s continued refusal or failure to perform (other than by reason of
Disability) Executive’s material duties and responsibilities to Company if such refusal or failure is not cured within thirty (30) days following written notice of such refusal or failure by Company to Executive, or
Executive’s continued refusal or failure to follow any reasonable lawful direction of the Board if such refusal or failure is not cured within thirty (30) days following written notice of such refusal or failure by Company to Executive;

 (ii) a material breach of this Agreement (other than Sections 7, 8 and 9) by Executive that, if capable of being cured, is not cured
within thirty (30) days following written notice of such breach by Company to Executive; 
 (iii) an intentional and material breach of
Sections 7, 8 and 9 hereof by Executive; 
 (iv) willful, grossly negligent or unlawful misconduct by Executive which causes material
harm to Company or its reputation; 
 (v) any conduct engaged in by Executive that is materially detrimental to the business or reputation
of Company as determined by the Board in good faith using its reasonable business judgment that is not cured within thirty (30) days following written notice from Company to Executive; 

(vi) Company is directed in writing by regulatory or governmental authorities to terminate the employment of Executive or Executive engages in
activities that (i) are not approved or authorized by the Board, and (ii) cause actions to be taken by regulatory or governmental authorities that have a material adverse effect on Company; or 

(vii) a conviction, plea of guilty, or plea of nolo contendere by Executive, of or with respect to a criminal offense which is a felony or
other crime involving dishonesty, disloyalty, fraud, embezzlement, theft or similar action(s) (including, without limitation, acceptance of bribes, kick-backs or
self-dealing), or the material breach of Executive’s fiduciary duties with respect to Company. 

(c) “Code” means the Internal Revenue Code of 1986, as amended. 

(d) “Company” has the meaning ascribed to it in the preamble of this Agreement. 

  
 11 

 (e) “Confidential Information” means any and all non-public information of Company. Confidential Information includes, without limitation, such information relating to (i) the development, research, testing, manufacturing, marketing and financial activities
of Company, (ii) the Services, (iii) the costs, sources of supply, financial performance and strategic and/or business plans of Company, (iv) the identity and special needs of the customers and prospective customers of Company, and
(v) the people and organizations with whom Company has business relationships and those relationships. Confidential Information also includes any information that Company has received, or may receive hereafter, belonging to customers or others
with any understanding, express or implied, that the information would not be disclosed. Notwithstanding the foregoing, “Confidential Information” does not include (x) any information that is or becomes generally known to the industry
or the public through no wrongful act of Executive or any representative of Executive and (y) any information that is made legitimately available to Executive by a third party without breach of any confidentiality obligation. 

(f) “Disability” means Executive’s inability, due to any illness, injury, accident or condition of either a physical or
psychological nature, to substantially perform Executive’s duties and responsibilities hereunder for a period of one hundred twenty (120) consecutive days, or for any one hundred and eighty (180) days during any period of three
hundred and sixty-five (365) consecutive calendar days, exclusive of any leave Executive may take under the Family and Medical Leave Act, 29 U.S.C. § 12101 et seq.
(“FMLA”) or as a reasonable accommodation under the Americans with Disabilities Act, 29 U.S.C. § 2601 et seq. (“ADA”). 

(g) “Final Compensation” means the amount equal to the sum of (i) the Base Salary earned but not paid through the date of
termination of employment, payable not later than the next scheduled payroll date, (ii) any business and related expenses and allowances incurred by Executive or to which Executive is entitled under Section 4(g) but unreimbursed on the
date of termination of employment; provided that with respect to business expenses unreimbursed under Section 4(g), such expenses and required substantiation and documentation are submitted within one hundred eighty (180) days of
termination in the case of termination on account of Executive’s death, or thirty (30) days on account of termination for any reason other than death, and that such expenses are reimbursable under Company’s applicable reimbursement
policy, and (iii) any other supplemental compensation, insurance, retirement or other benefits due and payable or otherwise required to be provided under Section 4 in accordance with the terms and conditions of the applicable plan or
agreement. 
 (h) “Good Reason” means, without Executive’s express written consent, (i) a material reduction in
the Base Salary, then in effect, except a material diminution generally affecting the members of the Company’s management, (ii) a material reduction in job title, position or responsibility, (iii) a material breach of any term or
condition contained in this Agreement, or (iv) a relocation of Executive’s principal worksite that is more than fifty (50) miles from Executive’s principal worksite as of the Start Date. However, none of the foregoing events or
conditions will constitute “Good Reason” unless (i) Executive provides Company with written notice of the existence of Good Reason within ninety (90) days following the occurrence thereof, (ii) Company does not reverse or
otherwise cure the event or condition within thirty (30) days of receiving that written notice, and (iii) Executive resigns Executive’s employment within thirty (30) days following the expiration of that cure period. 

  
 12 

 (i) “Intellectual Property” means inventions, discoveries, developments,
methods, processes, compositions, works, concepts and ideas (whether or not patentable or copyrightable or constituting trade secrets) conceived, made, created, developed or reduced to practice by Executive (whether alone or with others, whether or
not during normal business hours or on or off Company premises) during Executive’s employment that relate to either the Services or any prospective activity of Company or that make use of Confidential Information or any of the equipment or
facilities of Company. 
 (j) “Person” means an individual, a corporation, a limited liability company, an association, a
partnership, an estate, a trust and any other entity or organization, other than Company. 
 (k) “Sale of Company” means the
sale of Company to an independent third party or group of independent third parties pursuant to which such party or parties acquire (i) equity interests possessing the voting power under normal circumstances to elect a majority of the Board of
Directors or similar governing body of Company (whether by merger, consolidation or sale or transfer of such equity interests), or (ii) all or substantially all of Company’s assets determined on a consolidated basis. 

(l) “Services” means all services planned, researched, developed, tested, manufactured, sold, licensed, leased or otherwise
distributed or put into use by Company, together with all products provided or planned by Company, during Executive’s employment. 
 12.
Withholding. All payments made by Company under this Agreement may be reduced by any tax or other amounts required to be withheld by Company under applicable law or by any amounts authorized in writing by Executive. 

13. Assignment. Neither Company nor Executive may make any assignment of this Agreement or any interest herein, by operation of law or
otherwise, without the prior written consent of the other; provided, however, that Company may assign its rights and obligations under this Agreement without the consent of Executive in the event of a Sale of Company. This Agreement shall inure to
the benefit of and be binding upon Company and Executive, their respective successors, executors, administrators, heirs and permitted assigns. 

14. Compliance with Code Section 409A. 

(a) Notwithstanding any provision of this Agreement to the contrary, Executive’s employment will be deemed to have terminated on the date
of Executive “separation from service” (within the meaning of Treas. Reg. Section 1.409A-1(h)) with Company. 

(b) It is intended that this Agreement will comply with Section 409A of the Code, and any regulations and guideline issued thereunder
(“Section 409A”) to the extent that any compensation and benefits provided hereunder constitute deferred compensation subject to Section 409A. This Agreement shall be interpreted on a basis consistent with this intent. The
parties will negotiate in good faith to amend this Agreement as necessary to comply with Section 409A in a manner that preserves the original intent of the parties to the extent reasonably possible. No action or failure to act, pursuant to this
Section 14 shall subject Company to any claim, liability, or expense, and Company shall not have any obligation to indemnify or otherwise protect Executive from the obligation to pay any taxes pursuant to Section 409A of the Code. 

  
 13 

 (c) For purposes of the application of Treas. Reg.
§ 1.409A-1(b)(4)(or any successor provision), each payment in a series of payments will be deemed a separate payment. 

(d) Notwithstanding anything in this Agreement to the contrary, if any amount or benefit that would constitute
non-exempt “deferred compensation” for purposes of Section 409A of the Code would otherwise be payable or distributable under this Agreement by reason of Executive’s separation from service
during a period in which Executive is a “specified employee” (as defined under Code Section 409A and the final regulations thereunder), then, subject to any permissible acceleration of payment by Company under Treas. Reg. Section 1.409A-3(j)(4)(ii) (domestic relations order), (j)(4)(iii) (conflicts of interest), or (j)(4)(vi) (payment of employment taxes): 

(i) if the payment or distribution is payable in a lump sum, Executive’s right to receive payment or distribution of such non-exempt deferred compensation will be delayed until the earlier of Executive’s death or the first day of the seventh month following Executive’s separation from service; and 

(ii) if the payment or distribution is payable over time, the amount of such non-exempt deferred
compensation that would otherwise be payable during the six-month period immediately following Executive’s separation from service will be accumulated and Executive’s right to receive payment or
distribution of such accumulated amount will be delayed until the earlier of Executive’s death or the first day of the seventh month following Executive’s separation from service, whereupon the accumulated amount will be paid or
distributed to Executive and the normal payment or distribution schedule for any remaining payments or distributions will resume. 
 This Section 14(d)
should not be construed to prevent the application of Treas. Reg. § 1.409A-1(b)(9)(iii)(or any successor provision) to amounts payable hereunder (or any portion thereof). 

15. Golden Parachute Limitation. Notwithstanding anything in this section or elsewhere in this Agreement to the contrary, in the event
the payments and benefits payable hereunder to or on behalf of Executive (which the parties agree will not include any portion of payments allocated to the non-competition and
non-solicitation provisions of Sections 7 that are classified as payments of reasonable compensation for purposes of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”)),
when added to all other amounts and benefits payable to or on behalf of Executive, would result in the loss of a deduction under Code Section 280G, or the imposition of an excise tax under Code Section 4999, the amounts and benefits
payable hereunder shall be reduced to such extent as may be necessary to avoid such loss of deduction or imposition of excise tax. In applying this principle, the reduction shall be made in a manner consistent with the requirements of Code
Section 409A and where two or more economically equivalent amounts are subject to reduction, but payable at different times, such amounts shall be reduced on a pro-rata basis. All calculations required to
be made under this subsection will be made by the Company’s independent public accountants, subject to the right of Executive’s professional advisors to review the same. The parties recognize that the actual implementation of the
provisions of this subsection are complex and agree to deal with each other in good faith to resolve any questions or disagreements arising hereunder. 

  
 14 

 16. Indemnification. Company will indemnify Executive to the fullest extent permitted
by law, for all amounts (including, without limitation, judgments, fines, settlement payments, expenses and reasonable out-of-pocket attorneys’ fees) incurred or
paid by Executive in connection with any action, suit, investigation or proceeding, or threatened action, suit, investigation or proceeding, arising out of or relating to the performance by Executive of services for, or the acting by Executive as a
director, officer or employee of, Company, or any subsidiary of Company. Any fees or other necessary expenses incurred by Executive in defending any such action, suit, investigation or proceeding shall be paid by Company in advance, subject to
Company’s right to seek repayment from Executive if a determination is made that Executive was not entitled to indemnification. 
 17.
Severability. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision
in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. 

18. Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of
either party to require the performance of any term or obligation of this Agreement, or the waiver by either party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any
subsequent breach. 
 19. Survival. Sections 7 through 30 shall survive and continue in full force in accordance with their terms
notwithstanding the termination of Executive’s employment (and hence the Term of this Agreement) for any reason. 
 20. Notices.
Any and all notices, requests, demands and other communications provided for by this Agreement shall be in writing and shall be effective when delivered in person, with respect to notices delivered personally, or upon confirmed receipt when
delivered by facsimile or deposited with a reputable, nationally recognized overnight courier service and addressed or faxed to Executive at Executive’s last known address on the books of Company or, in the case of Company, at its principal
place of business, attention: Secretary, Board of Directors. 
 21. Entire Agreement. This Agreement constitutes the entire agreement
between the parties (including with respect to Company, its successors and assigns) with respect to Executive’s employment and supersedes all prior communications, agreements and understandings, written or oral, with respect to the terms and
conditions of Executive’s employment. 

  
 15 

 22. Amendment. This Agreement may be amended or modified only by a written instrument
signed by Executive and by an expressly authorized representative of Company. 
 23. Headings. The headings and captions in this
Agreement are for convenience only and in no way define or describe the scope or content of any provision of this Agreement. 
 24.
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be an original and all of which together shall constitute one and the same instrument. Furthermore, the delivery of a copy of such signature by
facsimile transmission or other electronic exchange methodology shall constitute a valid and binding execution and delivery of this Agreement by such party, and such electronic copy shall constitute an enforceable original document. Counterpart
signatures need not be on the same page and shall be deemed effective upon receipt. 
 25. Additional Obligations. Without implication
that the contrary would otherwise be true, Executive’s obligations under Sections 7 through 10 are in addition to, and not in limitation of, any obligations that Executive may have under applicable law (including any law regarding trade
secrets, duty of loyalty, fiduciary duty, unfair competition, unjust enrichment, slander, libel, conversion, misappropriation and fraud). 

26. Attorneys’ Fees. In any action or proceeding brought to enforce any provision of this Agreement, the prevailing party shall be
entitled to recover reasonable attorneys’ fees, costs and expenses from the other party to the action or proceeding. For purposes of this Agreement, the “prevailing party” shall be deemed to be that party who obtains substantially the
result sought, whether by settlement, mediation, judgment or otherwise, and “attorneys’ fees” shall include, without limitation, the reasonable
out-of-pocket attorneys’ fees incurred in retaining counsel for advice, negotiations, suit, appeal or other legal proceeding, including mediation and arbitration.

 27. Confidentiality. The parties acknowledge and agree that this Agreement and each of its provisions are and shall be treated
strictly confidential. During the Term and thereafter, Executive shall not disclose any terms of this Agreement to any person or entity without the prior written consent of Company, with the exception of Executive’s tax, legal or accounting
advisors or for legitimate business purposes of Executive, or as otherwise required by law. 
 28. No Rule of Construction. This
Agreement shall be construed to be neither against nor in favor of any party hereto based upon any party’s role in drafting this Agreement, but rather in accordance with the fair meaning hereof. 

29. Governing Law. This Agreement, the rights of the parties and all claims, actions, causes of action, suits, litigation,
controversies, hearings, charges, complaints or proceedings arising in whole or in part under or in connection herewith, will be governed by and construed in accordance with the domestic substantive laws of the state of Delaware, without giving
effect to any choice or conflict of law provision or rule that would cause the application of the laws of any other jurisdiction. 

  
 16 

 30. WAIVER OF JURY TRIAL. EXECUTIVE AND COMPANY EXPRESSLY WAIVE ANY RIGHT EITHER MAY
HAVE TO A JURY TRIAL CONCERNING ANY CIVIL ACTION THAT MAY ARISE FROM THIS AGREEMENT, OR THE RELATIONSHIP OF THE PARTIES HERETO. 

[Remainder of Page Intentionally Left Blank] 

  
 17 

 IN WITNESS WHEREOF, this Agreement has been executed by Company (by its duly authorized
representative) and by Executive, as of the date first above written. 
  

			
	STRATA SKIN SCIENCES, INC.
		
	By:	 	 /s/ Uri Geiger

		 	Name: Uri Geiger
		 	Title: Chairman of the Board
	
	EXECUTIVE:
	
	 /s/ Robert Moccia

	Robert Moccia

 EXHIBIT A 

Release of Claims 
 FOR
AND IN CONSIDERATION OF the benefits to be provided me in connection with the termination of my employment, as set forth in that certain Employment Agreement, dated as of March 1, 2021 (the “Agreement”), between me and STRATA
Skin Sciences, Inc. (the “Company”), or under any severance pay plan applicable to me, which benefits are conditioned on my signing this Release of Claims and to which I am not otherwise entitled, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, I, on my own behalf and on behalf of my heirs, executors, administrators, beneficiaries, representatives and assigns, and all others connected with me, hereby release and
forever discharge Company and any of its subsidiaries and Affiliates (as that term is defined in Section 11 of the Agreement) and all of their respective past, present and future officers, directors, trustees, equity holders, employees, agents,
managers, joint venturers, representatives, successors and assigns, and all others connected with any of them (collectively, the “Released Parties”), both individually and in their official capacities, from any and all causes of action,
rights and claims of any type or description, known or unknown, which I have had in the past, now have, or might now have, through the date of my signing of this Release of Claims, in any way resulting from, arising out of or connected with my
employment by Company or any of its Affiliates or the termination of that employment, including, but not limited to, any allegation, claim or violation arising under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act
of 1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older Worker Benefit Protection Act); the Equal Pay Act of 1963, as amended; the Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993;
the Worker Adjustment Retraining and Notification Act; Executive Retirement Income Security Act of 1974; the Fair Labor Standards Act; any applicable Executive Orders; or their state or local counterparts; or under any other federal, state or local
civil or human rights law, or under any other federal, state or local law, regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any policies, practices or procedures of Company; or any claim
for wrongful discharge, breach of contract, intentional infliction of emotional distress or defamation; or any claim for costs, fees or other expenses, including attorneys’ fees incurred in these matters (all of the foregoing collectively
referred to herein as “Claims”), other than (i) the right to payment of any vested or accrued benefits under any supplemental compensation, insurance, retirement and/or other benefit plan or agreement applicable to Executive,
(ii) the right to payment of any amounts owed to me by Company pursuant to Section 5 of the Agreement, (iii) any rights under applicable workers compensation or unemployment compensation laws, (iv) any rights that survive
termination of my employment pursuant to an option grant agreement or certificate to purchase Company’s (or an Affiliate’s) capital stock, (v) any rights with respect to Company’s (or an Affiliate’s) capital stock owned by
Executive or (vi) any rights to indemnification under the Agreement, Company’s by-laws or any other applicable law. 

In signing this Release of Claims, I acknowledge my understanding that I may not sign it prior to the termination of my employment, but that I
may consider the terms of this Release of Claims for up to twenty-one (21) days (or such longer period as Company may specify) from the later of the date my employment with Company terminates or the date
I receive this Release of 

  
 1 

 
Claims. I also acknowledge that I am advised by Company and its Affiliates to seek the advice of an attorney prior to signing this Release of Claims; that I have had sufficient time to consider
this Release of Claims and to consult with an attorney, if I wished to do so, or to consult with any other person of my choosing before signing; and that I am signing this Release of Claims voluntarily and with a full understanding of its terms.

 I represent that I have not filed against the Released Parties any complaints, charges, or lawsuits arising out of my employment, or any
other matter arising on or prior to the date of this Release of Claims, and covenant and agree that I will never individually or with any person file, or commence the filing of, any charges, lawsuits, complaints or proceedings with any governmental
agency, or against the Released Parties with respect to any of the matters released by me pursuant to this Release of Claims. 
 I further
acknowledge that, in signing this Release of Claims, I have not relied on any promises or representations, express or implied, that are not set forth expressly in the Agreement. I understand that I may revoke this Release of Claims at any time
within seven (7) days of the date of my signing by written notice to the Secretary, Board of Directors of Company (or such other person as Company may specify by notice to me given in accordance with the Agreement) and that this
Release of Claims will take effect only upon the expiration of such seven-day revocation period and only if I have not timely revoked it. 

Intending to be legally bound, I have signed this Release of Claims as of the date written below. 

 

			
	Signature:	 	  

		
	Name:	 	  

		
	Date Signed:	 	  

  
 2EX-10.4

 Exhibit 10.4 

STOCK OPTION AGREEMENT 

(Non-Qualified Stock Option) 

THIS STOCK OPTION AGREEMENT (this “Agreement”), dated as of March 1, 2021 (the “Grant Date”), is
between STRATA SKIN SCIENCES, INC., a Delaware corporation (the “Company”), and Robert Moccia, an adult individual (“Optionee”). 

NOW, THEREFORE, the parties hereto, in consideration of the mutual covenants contained herein, agree as follows: 

1. Non-Plan Grant; Incorporation of Terms of Plan. The Option is made and granted as a
stand-alone award, separate and apart from, and outside of, the Amended and Restated STRATA Skin Sciences, Inc. 2016 Omnibus Incentive Plan (the “Plan”), and shall not constitute an award granted under or pursuant to the Plan.
Notwithstanding the foregoing, the terms, conditions and definitions set forth in the Plan shall apply to the Option as though the Option had been granted under the Plan (including but not limited to the adjustment provision contained in the Plan),
and the Option shall be subject to such terms, conditions and definitions which are hereby incorporated into this Agreement by reference. For the avoidance of doubt, the Option shall not be counted for purposes of calculating the aggregate number of
Shares that may be issued or transferred pursuant to Awards under the Plan or for purposes of calculating the award limitations with respect to the Optionee under the Plan. 

2. Employment Inducement Grant. The Option is intended to constitute an employment inducement grant under NASDAQ Listing Rule
5635(c)(4), and consequently is intended to be exempt from the NASDAQ rules regarding shareholder approval of stock option and stock purchase plans. This Agreement and the terms and conditions of the Option shall be interpreted in accordance and
consistent with such exemption. 
 3. Grant of Option.

(a) In consideration, and as an inducement for the Optionee to enter into employment with the Company pursuant to an employment agreement dated
as of the Grant Date (“Employment Agreement”), the Company, on the Grant Date, hereby grants to Optionee an unvested option to purchase up to 1,632,590 shares of Common Stock (the “Option Shares”) at an exercise price of $____
per share (the “Option”). The Option shall be subject to the terms and provisions of this Agreement and of the Plan, which is incorporated herein by reference. 

(b) In consideration of the grant of the Option by the Company, the Optionee agrees to render faithful and efficient services to the Company
pursuant to the Employment Agreement. 
 4. Vesting. The Option shall vest and may be exercised in accordance with the following
vesting schedule: 
 (a) Options to purchase 544,198 Option Shares shall vest on March 1, 2022; and 

 (b) Options to purchase 136,049 Option Shares shall vest on each of June 1, 2022,
September 1, 2022, December 1, 2022, March 1, 2023, June 1, 2023, September 1, 2023, December 1, 2023, March 1, 2024; 

provided, however, that vesting shall accelerate and the right to purchase (i) all such Option Shares shall vest in full upon the consummation of a
Change in Control of the Company, and (ii) upon the occurrence of a termination by the Company other than for Cause, death or Disability (each as defined in the Employment Agreement) and pursuant to Section 5(d) of the Employment
Agreement, additional Option Shares shall vest as follows: (A) if such occurrence occurs prior to the first anniversary of the Grant Date, Optionee will be credited with an additional twelve (12) months of service as of such termination
date for purposes of determining the number of additional Option Shares that will vest pursuant to clauses (a) and (b) above, (B) if such occurrence occurs on or after the first anniversary of the Grant Date but prior to the date that is
eighteen (18) months following the Grant Date, Optionee will be credited with an additional eighteen (18) months of service as of such termination date for purposes of determining the number of additional Option Shares that will vest
pursuant to clause (b) above, and (C) if such occurrence occurs on or after the date that is eighteen (18) months following the Grant Date, all such Option Shares shall vest in full. The occurrence of the vesting of the Option Shares
pursuant to clause (ii) above shall occur upon the expiration of all applicable statutory revocation periods related to the Executive Release (as defined in the Employment Agreement) delivered pursuant to Section 5(d)(iii) of the
Employment Agreement. For purposes of clauses (ii)(A) and (ii)(B) above, to the extent such termination date, after giving effect to the applicable additional credited service, would occur before a threshold date set forth in clause (b) above,
Optionee shall not vest in Option Shares related to such threshold date or any subsequent threshold dates. 
 5. Term. The Option
shall continue in effect until the tenth (10th) anniversary of the Grant Date (the “Term”). During the Term, Optionee may exercise the Option in whole or in part at any time and
from time to time. Thereafter, the Option (to the extent vested and exercisable) shall expire and become unexercisable. The foregoing notwithstanding, subject to the other provisions of the Plan, if Optionee’s employment with, or
other service to, the Company terminates for any reason (other than death, Disability or Cause, as described in the Plan and as outlined below) or for no reason, then (i) any portion of the Option that is not then exercisable shall thereupon
terminate, and (ii) any portion of the Option that is then exercisable shall remain exercisable during the 90-day period following such termination or, if sooner, until the expiration of the Term and, to
the extent not exercised within such period, shall thereupon terminate. The foregoing notwithstanding, if Optionee’s employment with, or other service to, the Company terminates by reason of death or Disability, then the phrase “90-day period following such termination” in subsection (ii) above shall be replaced with the phrase “one-year period following such
termination.” In addition, notwithstanding anything to the contrary set forth herein, if Optionee’s employment or other service is terminated for Cause, then the Option, whether or not then exercisable, shall immediately terminate and
cease to be exercisable. 

 6. Manner of Exercising Option. 

(a) Subject to the satisfaction of the conditions contained in this Agreement, the Option may be exercised by delivering to the Secretary of
the Company a Notice of Exercise in the form attached hereto as Exhibit A, duly completed and executed by Optionee or his or her legal representative, together with payment in full for the shares of Common Stock purchased thereby. 

(b) Notwithstanding anything in this Agreement to the contrary, at the discretion of the Company, the aggregate exercise price of the
portion of this Option being exercised may be paid, in whole or in part, (i) by cash or check payable to the Company; (ii) by surrender to the Company of that number of fully paid and non-assessable
shares of Common Stock owned by Optionee based on the Fair Market Value (as that term is defined in the Plan) equal to applicable exercise price; or (iii) by means of a “net value” exercise which reduces the number of Option Shares to
be received upon such exercise to a “Net Number” of Option Shares determined according to the following formula: 
 Net Number = (A
x (B - C))/B. For purposes of the foregoing formula: 
 A = the total number of Option Shares with respect to which this Option is then
being exercised; 
 B = the last reported sale price (as reported by the principal national securities exchange on which the Common Stock is
then traded) of the Common Stock on the trading date immediately preceding the date of the applicable exercise of this Option; and 
 C =
the exercise price then in effect at the time of such exercise. 
 It is specifically intended that any such exercise contemplated hereunder be exempt from
the “short-swing profit” rule of Section 16(b) of the Exchange Act of 1934, as amended (the “Exchange Act”), as provided by Rule 16b-3 of the Exchange Act. 

7. Release. By signing below, Optionee, on behalf of himself or herself, his or her successors and assigns, hereby releases and
forever discharges the Company and the present and former officers, directors, shareholders, employees, agents and attorneys of each of them from any and all actions, causes of action, damages, judgments, liabilities, obligations and claims
whatsoever, in law or in equity, whether known or unknown, relating to, and covenants not to sue based on, any and all of the Company’s commitments made by the Company prior to the date hereof to issue Optionee stock options or other equity
incentives. Specifically, the Optionee acknowledges that this Option grant satisfies the obligation of the Company pursuant to Section 4(c) of the Employment Agreement. 

8. No Transfer or Assignment. The Option may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any
manner other than by (i) will and by the laws of descent and distribution and (ii) during the lifetime of Optionee, to the extent and in the manner authorized by the Compensation Committee, but only to the extent such transfers are made to
family members, to family trusts, to family controlled entities, to charitable organizations, and pursuant to domestic relations orders, in all cases without payment for such transfers. Any purported sale, pledge, assignment, hypothecation,
transfer, or disposition in contravention of this Section 8 shall be null and void ab initio. 

 9. Compliance with Laws and Regulations. 

(a) The Company will not be obligated to issue or deliver shares of Common Stock pursuant to the Plan unless the issuance and delivery of such
shares complies with applicable law, including, without limitation, the Securities Act of 1933, as amended, the Securities Act of 1934, as amended, and the requirements of any stock exchange or market upon which the Common Stock may then be listed,
and shall be further subject to the approval of counsel for the Company with respect to such compliance. 
 (b) In connection with the
exercise of this Option, Optionee will execute and deliver to the Company such representations in writing as may be requested by the Company that it may comply with the applicable requirements of federal and state securities laws. 

10. Notices. All notices, requests, demands, waivers, consents, approvals or other communications pursuant to this Agreement shall
be in writing and delivered to the Company at its principal executive offices, Attention: Secretary, or to Optionee at the residence address reflected in the records maintained by the Company. 

11. No Rights of Stockholder. Neither Optionee nor any legal representative of Optionee shall be, or have any of the rights and
privileges of, a stockholder of the Company with respect to any shares subject to the Option except to the extent that certificates for such shares shall have been issued upon the exercise of the Option as provided for herein. 

12. Construction. The Compensation Committee shall have exclusive authority to interpret and construe the Plan and the Option, and
its determinations with respect thereto shall be final and binding on the Company and Optionee. In the event of any conflict between the Plan and this Agreement, the terms of this Agreement shall control. 

13. No Rights Conferred. Nothing contained in this Agreement shall confer upon Optionee any right with respect to the continuation
of his or her employment or other service with the Company or its subsidiaries or interfere in any way with the right of the Company and its subsidiaries at any time to terminate such employment or other service or to increase or decrease, or
otherwise adjust, the other terms and conditions of Optionee’s employment or other service. 
 14. Withholding. All amounts
that, under federal, state or local law, are required to be withheld from the amount payable with respect to the Option shall be withheld by the Company. 

15. Representations. The Optionee has reviewed with his or her own tax advisors the applicable tax (federal, state, and local)
consequences of the transactions contemplated by this Agreement. The Optionee is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Optionee understands that the Optionee (and not
the Company) shall be responsible for any tax liability that may arise as a result of the transactions contemplated by this Agreement. 
 16.
Investment Representation. The Optionee hereby represents and warrants to the Company that the Optionee, by reason of the Optionee’s business or financial experience (or the business or financial experience of the Optionee’s
professional advisors who are unaffiliated with and who are not compensated by the Company or any affiliate or selling agent of the Company, directly or indirectly), has the capacity to protect the Optionee’s own interests in connection with
the transactions contemplated under this Agreement. 

 17. Acceptance. The Optionee hereby acknowledges receipt of a copy of the Plan and
this Agreement. The Optionee has read and understand the terms and provision thereof, and accepts the Option subject to all the terms and conditions of the Plan and this Agreement. 

18. Entire Agreement; Amendment. This Agreement, the Employment Agreement and the Plan sets forth the entire understanding of the
parties hereto with respect to the subject matter hereof. This Agreement may not be amended or supplemented except by a written instrument duly executed by each of the parties hereto; provided, however that the Company’s Board of Directors
or Compensation Committee may amend the terms of this Agreement at any time without the written consent of Optionee provided that such amendment does not adversely affect the rights of Optionee. 

19. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without
regard to its principles of conflict of laws. 
 [Signature page follows] 

 IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officer, and Optionee has executed this Agreement, as of the day and year above written. 
  

							
	STRATA SKIN SCIENCES, INC.	 		 	OPTIONEE:
				
	By:	 	              
	 	        	 	  

	Name:	 		 		 	Robert Moccia
	Title:	 		 		 	

 Exhibit A 

NOTICE OF EXERCISE 
  

	TO:	 STRATA Skin Sciences, Inc. 

The undersigned hereby exercises his/her option to purchase _____ shares of Common Stock of STRATA Skin Sciences, Inc. (the
“Company”), as provided in the Stock Option Agreement dated as of ________________ $____ per share, for an aggregate purchase price of $ _____________ (the “Purchase Price”). 

The undersigned is hereby paying the Purchase Price as follows (check one of the following): 

____         (i) The undersigned has enclosed herewith payment by cash or check made payable to the
order of the Company in the amount of the Purchase Price; or 
 ____         (ii) The undersigned has
received the prior approval of the Company that it will accept payment of the Purchase Price by the surrender to the Company of that number of fully paid and non-assessable shares of Common Stock owned by the
undersigned Optionee which have an aggregate value equal to the Purchase Price and the undersigned has therefore enclosed herewith stock certificate number __ representing a total of ______ shares of Common Stock in order to surrender to the Company
____ shares of Common Stock in payment of the Purchase Price; or 
 ____         (iii) The
undersigned has received the prior approval of the Company that it will accept payment of the Purchase Price by means of a “net value” exercise and the undersigned hereby requests the Company to deliver to him/her ______ shares of Common
Stock (the number of shares derived by a net value exercise) in full satisfaction of the exercise hereunder. 
 The undersigned hereby
represents and warrants that it is his/her present intention to acquire and hold the aforesaid shares of Common Stock of the Company for his/her own account for investment, and not with a view to the distribution of any thereof, and agrees that
he/she will make no sale, thereof, except in compliance with the applicable provisions of the Securities Act of 1933, as amended. 
  

			
	Signature:	 	  

		
	Name (print)	 	  

		
	Address:	 	  

		
		 	  

		
	Dated:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}]]